These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 21720813

  • 1. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.
    Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Deuter C.
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1235-43. PubMed ID: 21720813
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil in the treatment of uveitis in children.
    Doycheva D, Deuter C, Stuebiger N, Biester S, Zierhut M.
    Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil for ocular inflammation.
    Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH.
    Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178
    [Abstract] [Full Text] [Related]

  • 4. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation.
    Lau CH, Comer M, Lightman S.
    Clin Exp Ophthalmol; 2003 Dec; 31(6):487-91. PubMed ID: 14641155
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
    Siepmann K, Huber M, Stübiger N, Deuter C, Zierhut M.
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis.
    Bhat P, Cervantes-Castañeda RA, Doctor PP, Anzaar F, Foster CS.
    Ocul Immunol Inflamm; 2009 Jul; 17(3):185-90. PubMed ID: 19585361
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil for the treatment of uveitis.
    Teoh SC, Hogan AC, Dick AD, Lee RW.
    Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP.
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L, Christen W, Foster CS.
    Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [Abstract] [Full Text] [Related]

  • 10. [Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].
    Zierhut M, Stübiger N, Aboalchamat W, Landenberger H, Bialasiewicz AA, Engelmann K.
    Ophthalmologe; 2001 Jul; 98(7):647-51. PubMed ID: 11490743
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil monotherapy in the management of paediatric uveitis.
    Chang PY, Giuliari GP, Shaikh M, Thakuria P, Makhoul D, Foster CS.
    Eye (Lond); 2011 Apr; 25(4):427-35. PubMed ID: 21423146
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil in the therapy of uveitic macular edema--long-term results.
    Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Deuter C.
    Ocul Immunol Inflamm; 2012 Jun; 20(3):203-11. PubMed ID: 22489750
    [Abstract] [Full Text] [Related]

  • 13. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
    Greiner K, Varikkara M, Santiago C, Forrester JV.
    Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil as an immunomodulator in refractory noninfectious uveitis.
    Rodriguez EE, Sakata VM, Cavalcanti DC, Zaghetto JM, Olivalves E, Hirata CE, Yamamoto JH.
    Arq Bras Oftalmol; 2016 Sep; 79(6):369-372. PubMed ID: 28076562
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
    Cuchacovich M, Solanes F, Perez C, Verdaguer JI, Verdaguer J, Castiglione E, Carpentier C, Traipe L, Villarroel F.
    J Ocul Pharmacol Ther; 2016 Sep; 32(1):55-61. PubMed ID: 26562247
    [Abstract] [Full Text] [Related]

  • 16. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM.
    Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
    [Abstract] [Full Text] [Related]

  • 17. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.
    Rathinam SR, Babu M, Thundikandy R, Kanakath A, Nardone N, Esterberg E, Lee SM, Enanoria WT, Porco TC, Browne EN, Weinrib R, Acharya NR.
    Ophthalmology; 2014 Oct; 121(10):1863-70. PubMed ID: 24917273
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate Mofetil for the Treatment of Multiple Sclerosis-associated Uveitis.
    Hedayatfar A, Falavarjani KG, Soheilian M, Elmi Sadr N, Modarres M, Parvaresh MM, Naseripour M, Rohani M, Almasi M, Chee SP.
    Ocul Immunol Inflamm; 2017 Jun; 25(3):308-314. PubMed ID: 27379567
    [Abstract] [Full Text] [Related]

  • 19. Outcomes in Patients With Vogt-Koyanagi-Harada Disease From the First-Line Antimetabolites for Steroid-Sparing Treatment Uveitis Trial.
    Acharya NR, Rathinam SR, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Gonzales JA, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Arellanes-Garcia L, Coyne A, Porco TC, Shantha JG, FAST Research Group.
    Am J Ophthalmol; 2024 Nov; 267():100-111. PubMed ID: 38909740
    [Abstract] [Full Text] [Related]

  • 20. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
    Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Keenan JD, Rao MM, Ebert CD, Nguyen HH, Kim E, Porco TC, Acharya NR, FAST Research Group.
    JAMA; 2019 Sep 10; 322(10):936-945. PubMed ID: 31503307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.